Literature DB >> 14982048

Risk factors for pterygium in an adult Jordanian population.

Muawyah Al-Bdour1, Mo'tasem M Al-Latayfeh.   

Abstract

PURPOSE: To evaluate the risk factors for the development of pterygium in a Middle Eastern country (Jordan) and to compare our finding with those from other countries.
METHODS: This study was conducted in Irbid District, in northern Jordan, a region located 31 degrees north of the equator, with a stable, subtropical climate. In this case control study, 96 adult subjects presenting with pterygium were interviewed and compared to 192 control subjects who were group-matched for age and sex. A standard questionnaire and eye examination were completed for both groups.
RESULTS: There was a strong positive association between pterygium and environmental factors. The most striking increase in the risk of pterygium occurred in subjects who worked outdoors compared to those who worked indoors, with an odds ratio of 5.47. Current and previous sunlight exposures were associated with a higher risk of developing pterygium, with odds ratios of 3.54 and 4.52, respectively. Previous use of sunglasses represented a protective element, but the protective role of recent use of sunglasses was not statistically significant.
CONCLUSION: There is a statistically significant association between outdoor work, sunlight exposure and pterygium formation. Efforts should be made to educate outdoor workers to wear sunglasses and brimmed hats. Public education should focus on avoidance of unnecessary sunlight exposure.

Mesh:

Year:  2004        PMID: 14982048     DOI: 10.1046/j.1600-0420.2003.0213.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  15 in total

Review 1.  [Epidemiology of pterygium. A review].

Authors:  K Droutsas; W Sekundo
Journal:  Ophthalmologe       Date:  2010-06       Impact factor: 1.059

2.  Matrix Metalloproteinase-14 as an Instigator of Fibrosis in Human Pterygium and Its Pharmacological Intervention.

Authors:  Cesar Masitas; Zhihong Peng; Man Wang; Mohini Mohan Konai; Luis F Avila-Cobian; Leslie Lemieux; John Hovanesian; James E Grady; Shahriar Mobashery; Mayland Chang
Journal:  ACS Pharmacol Transl Sci       Date:  2022-07-19

3.  Prevalence and risk factors for eye diseases, blindness, and low vision in Lhasa, Tibet.

Authors:  Gui-Qin Wang; Zong-Xi Bai; Jing Shi; Sang Luo; Hong-Fa Chang; Xiao-Yong Sai
Journal:  Int J Ophthalmol       Date:  2013-04-18       Impact factor: 1.779

4.  Preoperative factors influencing success in pterygium surgery.

Authors:  Ana Torres-Gimeno; Lucía Martínez-Costa; Guillermo Ayala
Journal:  BMC Ophthalmol       Date:  2012-08-08       Impact factor: 2.209

5.  The prevalence of pterygium in Alkhobar: A hospital-based study.

Authors:  Jerman M Alqahtani
Journal:  J Family Community Med       Date:  2013-09

6.  Geographical prevalence and risk factors for pterygium: a systematic review and meta-analysis.

Authors:  Lei Liu; Jingyang Wu; Jin Geng; Zhe Yuan; Desheng Huang
Journal:  BMJ Open       Date:  2013-11-19       Impact factor: 2.692

7.  The prevalence and risk factors for pterygium in South Korea: the Korea National Health and Nutrition Examination Survey (KNHANES) 2009-2010.

Authors:  Eun-Young Pyo; Gui Hyeong Mun; Kyung Chul Yoon
Journal:  Epidemiol Health       Date:  2016-04-29

8.  Demographics of Patients with Double-headed Pterygium and Surgical Outcomes.

Authors:  Fulya Duman; Mustafa Köşker
Journal:  Turk J Ophthalmol       Date:  2015-12-05

9.  Associations between arsenic in drinking water and pterygium in southwestern Taiwan.

Authors:  Wei Lin; Shu-Li Wang; Horng-Jiun Wu; Kuang-Hsi Chang; Peter Yeh; Chien-Jen Chen; How-Ran Guo
Journal:  Environ Health Perspect       Date:  2008-07       Impact factor: 9.031

10.  Prevalence and associated factors for pterygium in rural agrarian central India. The central India eye and medical study.

Authors:  Vinay Nangia; Jost B Jonas; Deepa Nair; Nandita Saini; Prabhat Nangia; Songhomitra Panda-Jonas
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.